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INTRODUCTION
Tissue bioengineering appears as a tool capable 
of using cells, growth factors and scaffolds to create 
autogenous tissues in laboratory and apply them as 
therapeutic agents (1).
Periosteum-derived cells (PDC) have osteogenic 
potential (2-5). They are an alternative cell source in 
comparison with bone marrow in the tissue engineering 
field since they require less invasive and safer techniques 
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The aim of this study was to evaluate the bone repair using autogenous periosteum-derived cells (PDC) and bovine anorganic apatite 
and collagen (hA-COl). PDC from Wistar rats (n=10) were seeded on hA-COl discs and subjected to osteoinduction during 6 days. 
Critical-size defects in rat calvarias were treated with blood clot (G1), autogenous bone (G2), hA-COl (G3) and hA-COl combined 
with PDC (G4) (n=40), and then analyzed 1 and 3 months after surgeries. radiographic analysis exhibited no significant temporal 
change. G1 and G2 had discrete new marginal bone, but the radiopacity of graft materials in G2, G3 and G4 impaired the detection of 
osteogenesis. At 3 months, histopathological analysis showed the presence of ossification islets in G1, which was more evident in G2, 
homogeneous new bone around hA-COl in G3 and heterogeneous new bone around hA-COl in G4 in addition to moderate presence 
of foreign body cells in G3 and G4. histomorphometric analysis showed no change in the volume density of xenograft (p>0.05) and 
bone volume density in G2 was twice greater than in G1 and G4 after 3 months (p<0.05), but similar to G3. The PDC did not increase 
bone formation in vivo, although the biomaterial alone showed biocompatibility and osteoconduction capacity.
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to obtain the osteogenic cells. Also, PDC show greater 
proliferation, which decreases the time of cell culture, 
contamination risks and experiment costs. It could be 
a favorable alternative for dentists as a regenerative 
therapy for alveolar bone to treat periodontitis and dental 
implant dehicenses, due to the easy handling, expansion 
and re-implantation of cells (2).
Cell culture is done upon scaffolds to simulate the 
3D structure of bone tissue. Demineralized and acelullar 
bovine xenograft matrices are predominantly composed 
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by collagen (COl), biocompatible (6), biodegradable 
and allow adhesion, growing and cellular differentiation 
(7). On the other hand, anorganic xenograft free of cells 
and organic mater is mainly constituted of a natural 
hydroxyapatite (hA), which can be biocompatible, 
osteoconductive and osteoinductive (8). Combination 
of both has shown spreading of human osteoblasts after 
eleven days in vitro (9) and new bone formation in femur 
(10) and rat skull (11) after 2-3 months. In a previous 
study, PDC-COl showed hundred times more bone in 
central area of rat calvaria critical-size defects (rcCsD) 
in comparison with the control group (5). PDC-hA 
implanted in subcutaneous tissue induced heterotopic 
ossification (4). 
Combination of hA and COl could enhance the 
ability to carry progenitor cells to bone defects, since the 
agglutinating capacity of COl will be combined with the 
osteoconduction property of hA (6). Thus, the aim of 
this study was evaluate the bone repair in rcCsD using 
autogenous PDC and a bovine xenograft.
MATERIAL AND METHODS
Cellular Isolation and Expansion
Male adult Wistar rats (Rattus norvegicus albinus, 
n=10) under systemic anesthesia with hydrochloride 
ketamine (60 mg/kg, Francotar; virbac do Brasil ltda., 
são Paulo, sP, Brazil) and hydrochloride xylazine (12 
mg/kg, rompum, Bayer s.A., são Paulo, sP, Brazil) 
had the frontal-parietal region incised in half-moon to 
create partial flap to harvest the intact periosteum. each 
biopsied tissue sample measuring 1 cm² was digested 
in 0.25% colagenase (sigma-Aldrich Corp., st. louis, 
MO, usA) for 2 h and cell suspension incubated with 
DMeM:hAMF12 and 10% bovine fetal serum (Cultilab, 
são Paulo, sP, Brazil) at 37ºC, 5% CO2 and 95% wet 
atmosphere. The PDC exhibited adherence to tissue 
culture acrylic plate after 4 h, typical fibroblast-like 
morphology within 3 days and constituted a cellular 
monolayer, which had medium replacement every 2 
days. Cells were continuously cultivated until passage 
2 for the bioengineering studies. von Kossa staining 
and alkaline phosphatase (AlP) assay confirmed the 
osteogenic potential of PDC (data not shown). 
Cellular Seeding in HA-COL Scaffold
Disks (8 x 1.5 mm) of natural bovine xenograft 
(75% hA, 25% COl) were incubated in 24-well 
plates in the same conditions for 24 h, considering the 
crucial importance of protein adsorption in the initial 
cellular adhesion step, previously to seeding of 1.0x105 
autogenous PDC in passage 2 onto xenograft. The 
medium was supplemented with 20 nM dexamethasone, 
50 μg/mL ascorbic acid and 10 mM β- glycerophosphate 
(sigma-Aldrich Corp.), replaced every 2 days, and the 
set was maintained in cell culture for 6 days (2) until 
surgery. Additional samples (n=3) were processed for 
ultrastructural morphological evaluation of cell-material 
interface following the protocol: fixation in Karnovsky’s 
solution for 1 h, washing with cacodilate buffer 0.1 
M ph 7.2, fixation in 1% osmium tetroxide for 1 h, 
dehydration in an increasing ethanol series (30, 50, 70, 90 
and 100%, 10 min each), critical point drying (CPD.030; 
BAl-Tec AG, liechtenstein), sputter-coating with gold 
and analysis with a scanning electron microscope (JsM-
5800lv; JeOl, Tokyo, Japan) (Fig. 1).
Figure 1. Incubation of PDC with hA-COl graft (A). seM micrograph showing cell adhesion on hA granules in 6 days after seeding (B).
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Critical-Size Defects in Rat Calvaria
Adult rats (n=40, including the 10 donor/host 
animals of autogenous PDC) were put under systemic 
anesthesia, incised in the skull for a total flap and 
creation of rcCsD with an 8-mm diameter trephine bur 
(sIn, são Paulo, sP, Brazil). The osteotomized fragment 
was removed thoroughly and the defect was full filled 
with: blood clot (Group 1 - G1 - negative control), 
autogenous particulate bone from skull (Group 2 - G2 
- positive control), hA-COl xenograft (Group 3 - G3) 
and hA-COl xenograft with autogenous PDC (Group 
4 - G4). Afterwards, the flap was replaced and sutured. 
euthanasia by anesthetic overdose occurred at 1 (n=20) 
and 3 months (n=20) after surgery and the skull samples 
were fixed with 4% buffered formalin for 48 h. 
Radiographic Processing and Evaluation
The parameters for digital radiographs of 
skulls with a microfocus x-ray machine (FXs-100.10; 
Feinfocus usA Inc., Trenton, nJ, usA) were 40 kv 
tension, 125 μA electric chain, exposure time of 600 s, 
source-detector distance of 2 m, source-object of 40 cm, 
×5 factor of magnification, 50 μm pixel size and x-ray 
focal size of ~10 μm. Phosphorous plate detected latent 
image (Image Plate IPX; Ge Inspection Technologies 
Gmbh, huerth, Germany) using a desk scanner (Cr-
50P; Ge Inspection Technologies Gmbh).
Histopathological Processing and Evaluation
The excisional necropsies of skulls were 
decalcified in fast bone demineralization solution 
(Allkimia Comércio de Materiais para laboratórios ltda., 
Campinas, sP, Brazil) for 48 h, washed for 1 h, dehydrated 
in ethanol (vetec Química Fina ltda., Duque de Caxias, 
rJ, Brazil), clarified in xylol (vetec Química Fina ltda.), 
impregnated and included in paraffin (vetec Química 
Fina ltda.). Five-micrometer-thick sections were stained 
by hematoxylin-eosin and examined by an experienced 
pathologist. Descriptive analysis, comparative of intra- 
and inter-group biological response, was based on the 
type and intensity of inflammatory alterations and repair 
processes (fibrosis, new blood vessels and osteogenesis). 
Photomicrographs were obtained with a digital camera 
(Cybershot DsC-W300; sony, Manaus, AM, Brazil) 
connected to an optical microscope (FWl-1000; Feldman 
Wild leitz, Manaus, AM, Brazil). 
Histomorphometric and Statistical Analyses
Digital images of non-superimposed contiguous 
fields (6-8 per slide, ×170 magnification) covered the 
extension of rcCsD allowed the analysis using Image 
Pro-Plus 6.0 (Media Cybernetics, san Diego, CA, 
usA), calibrated in micrometers/pixel and with a 100 
points grade (12). Determination of number of points 
upon connective tissue, blood tissue, new bone tissue, 
old bone tissue and graft biomaterial permitted the 
calculation of volume density of each parameter. Two 
independent and calibrated researchers evaluated the 
images (maximum media variation lower than 0.01%, 
paired t test (Instat 3.01; Graphpad software Inc., san 
Diego, CA, usA). Mean volume density and standard 
deviation data were subjected to AnOvA and Tukey’s 
test, considering significant differences if p<0.05.
RESULTS
rat PDC on passage 2 cultivated in an osteogenic 
medium were capable of differentiating and producing 
mineralized nodules after 21 days (data not shown), 
confirmed by AlP assay and von Kossa staining, 
respectively. ultrastructural analysis of PDC after 6 days 
culture over hA-COl showed cell attachment on apatite 
granules (Fig. 1). The rcCsD were filled with blood clot, 
autogenous bone, hA-COl and hA-COl plus PDC.
Radiographic Analysis 
At 1 month, there was no bone formation at the 
center of the rcCsD. G1 and G2 had mild peripheral 
alteration suggesting bone growing toward the middle 
of the rcCsD, while G3 and G4 showed xenograft filling 
the rcCsD with lower level of gray than old bone. 
At 3 months, G1 showed suggestive image of 
new bone from border to center of the lesion presenting 
sharp margins and levels of gray similar to old bone. G2 
showed rcCsD almost full filled of irregular autograft 
fragments presenting levels of gray similar to old bone. 
In G3 and G4, the xenograft was in close contact to the 
bone margin of the rcCsD, but still with a low level of 
gray in comparison with old bone.
Histopathological Analysis 
histopathological analysis of the middle of the 
rcCsD at 1 month showed in G1 (Fig. 2A) presence of 
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Figure 2. histopathological analysis. After 1 month: Bone islets (arrow) in the middle of defect surrounded by fibrous connective tissue 
(*,A); new bone (nB) in contact to old bone (OB) with fibrous tissue (*) and blood vessel (white arrow head, B); Different size particles 
of biomaterial (B, hA-COl) without (C) or with cells (D) surrounded by loose connective with blood vessels (white arrow head). After 
3 months. Discrete increase in the size of new bone in G1 (e) in opposition to large amount of bone in G2 containing blood vessels 
(white arrow head, F); new bone in contact to xenograft biomaterial (G and h, black arrow) surrounded by fibrous connective tissue (*).
loose to dense connective tissue, surrounding islets of 
bone tissue originated by intramembranous ossification. 
In G2 (Fig. 2B), presence of distinct fragments of old 
bone, interposed by connective tissue, blood vessels 
and reversion lines indicating the beginning of new 
bone formation were observed. The findings in G3 (Fig. 
2C) were presence of granules of hA in different sizes 
interposed by loose connective tissue with moderate 
presence of multinucleated foreign body giant cells 
(MGC), new blood vessels and areas of intramembranous 
ossification. In G4 (Fig. 2D), there was intense presence 
of cells around the hA, still surrounded by some MGC. 
At 3 months, G1 (Fig. 2e) was filled with 
connective tissue and new amorphous bone in greater 
density. In G2 (Fig. 2F), fragments of fused autogenous 
bone inducing new and well-cellularized bone formation 
with blood vessels could be seen. In G3 (Fig. 2G), there 
was ossification around and directly in contact to hA in 
Braz Dent J 22(4) 2011 
326 A.O. Paulo et al.
Figure 3. Images from border to border in each experimental group obtained from histomorphometric analysis (A). volume density was 
determined for new bone (B), connective tissue (C), blood vessel (D) and residual biomaterial (e). Bars represent the 95% confidence 
interval of five animals per group.
a moderate intensity (substitution of granule by bone) 
and homogenous way, though areas of dense connective 
tissue with some MGC were found. In G4 (Fig. 2h), 
there were hA granules interposed by dense connective 
tissue with focal or heterogeneous areas of ossification 
and some MGC, from mild to moderate intensity. 
Histomorphometric Analysis
histomorphometric analysis (Fig. 3A) showed 
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that there was greater bone formation in G2 similar to 
G3 in comparison to G1 and G4, but similar levels in 
G4 and G1, after 3 months (Fig. 3B). no significant 
difference was found for connective tissue (Fig. 3C) 
and blood vessels density volume among groups at 
either of the evaluation times (Fig. 3D). The presence 
of biomaterial (G3 and G4) throughout the experimental 
period suggested absence of degradation (Fig. 3e).
DISCUSSION
Cell-based therapy of bone loss has been 
increasingly studied but gaps still remains. The results 
of this study showed that PDC used in combination with 
a xenograft composite (hA-COl) did not enhance bone 
repair of rcCsD. 
Primary cultures have limitations because they can 
present a mixture of osteoblast cells in different stages 
of differentiation besides other lineages. On the other 
hand, well-differentiated cells are difficult to expand and 
they could lose their osteogenic potential. Mesenchymal 
stem cells can easily proliferate, but directing them to 
osteogenic differentiation still is a greater challenge. Co-
culture of both cells have shown later mineralization (13). 
Bone marrow is an usual source of bone cells (14), but 
harvesting these cells are frequently related to pain and 
morbidity. Alternatively, periosteum has been reported 
as a reliable source of osteogenic cells (15,16) allowing 
bone reconstruction around dental implants (17).
The rcCsD is a good model to study bone 
therapies due to its morphological similarity to 
maxillofacial region, allowing radiographic and 
histological analyses. Also, the fact that no complete 
repair occurs during the animal life allows evaluating 
the biomaterial functionality (6).
Although digital radiography produces enhanced 
images than conventional processing (11), it was not 
possible to discriminate bone and biomaterial structures, 
due to the very similar intensity in their gray scale, 
impairing counting of the area of new bone in G3 and G4. 
On the other hand, histological analysis confirmed that 
the rcCsD did not regenerate during the experimental 
period observed as previously reported, presenting a 
fibrous tissue fulfilling the bone defect (6,11,18,19). In 
addition, the inflammatory reaction to hA enables the 
recruitment of MGC around the biomaterials particles 
and, on the other hand, the use of autograft induces the 
almost complete closing of bone defect (6,11,18,19).
The normal bone repair of rcCsD varies from 
7.6% (18) in 8 weeks to 12% in 12 weeks (20). The use 
of biomaterials increases these values, from 15.8% (18) 
to 40% in 8 weeks and from 24% (20) to 53.54% (15) 
in 12 weeks. Cell therapy has shown positive results 
using PDC and carriers, producing 3 times more bone 
augmentation with poly (glycolic-co-lactic acid) (PlGA) 
(3) or 6 times with COl (5) compared to untreated 
groups. In comparison with the carrier alone, the 
combination reaches twice the efficacy with PGlA (3). 
PDC have been shown to present osteogenic 
potential and adherence to COl carrier, but they did 
not show greater new bone formation rcCsD than the 
material alone (21). Cell behavior is influenced by 
topography of the material (22). hA with regular surfaces 
stimulate proliferation, protein synthesis, AlP activity 
and presence of mineralization nodules (23). however, 
long-term contact (6 months) between trabecular bone-
derived cells and natural apatite (anorganic bovine 
bone) grafted in human maxilla inhibits osteoblast-like 
phenotype in vitro (24). Further longer pre-culture periods 
have a critical role in differentiation process for lead to 
a progressively diminishing of osteoinductivity (25). In 
this way, the worst performance of the xenograft with 
cells could be explained by (i) unfavorable adhesion and 
the challenge to differentiate PDC upon inappropriate 
material as cell carrier during the experimental period or 
(ii) inhibition of cellular proliferation and osteoinductive 
potential due to long pre-culture period in osteogenic 
media in vitro (6 days) before implantation into an 
orthotopic site (rcCsD) for in vivo study. new strategies 
must be developed to improve the synergistic success of 
cell therapy with PDC and the composite carrier.
Within the limitations of this study, it may be 
concluded that combination of PDC with xenograft 
based on hA-COl did not enhance osteogenesis in 
rcCsD, despite biomaterial biocompatibility and 
osteoconduction capacity. The biomaterial alone showed 
similar efficiency as that of autogenous bone and appears 
as a good choice for bone loss therapies.  
RESUMO
O objetivo deste estudo foi avaliar o reparo ósseo usando células 
derivadas de periósteo (PDC) e apatita inorgânica e colágeno 
bovinos (hA-COl). PDC de ratos Wistar (n=10) foram semeadas 
sobre discos de hA-COl e osteoinduzidas por 6 dias. Defeitos de 
tamanho crítico em calvárias de ratos foram tratados com coágulo 
sanguíneo (G1), osso autógeno (G2), hA-COl (G3) ou hA-COl 
associado a PDC (G4) (n=40) e analisados em 1 e 3 meses após 
as cirurgias. Análise radiográfica não exibiu mudança temporal 
significante, G1 e G2 tiveram aumento discreto de novo osso 
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marginal, entretanto a radiopacidade dos materiais de enxerto 
em G2, G3 e G4 prejudicou a detecção de osteogênese. Análise 
histopatológica mostrou em 3 meses ilhotas de ossificação em G1 
que foi maior em G2, novo osso homogêneo ao redor de hA-COl 
em G3 e novo osso heterogêneo ao redor de hA-COl em G4 além 
da presença moderada de células gigantes de corpo estranho em G3 
e G4. Análise histomorfométrica mostrou a densidade de volume 
inalterada do xenoenxerto (p>0,05) e a densidade de volume de 
novo osso em G2 duas vezes maior que G1 e G4 após 3 meses 
(p<0,05), mas similar a G3. PDC não aumentaram a formação 
óssea in vivo apesar do biomaterial sozinho ter apresentado 
biocompatibilidade e capacidade osteocondutora.
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